Elevated ALDOB levels correlate with unfavorable postoperative prognosis in CRC patients, colon cancer liver metastases, and response to neoadjuvant chemoradiotherapy in rectal cancer patients [19–21]. Here, ALDOB is linked to colorectal carcinoma.